| Tag | Content |
|---|
EnhancerAtlas ID | HS018-01677 |
Organism | Homo sapiens |
Tissue/cell | CD19+ |
Coordinate | chr1:173375520-173377550 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| IRF1 | MA0050.2 | chr1:173376029-173376050 | GGGGTGAAAGTGAAAGTGAAC | - | 7.39 | | IRF2 | MA0051.1 | chr1:173376033-173376051 | TGAAAGTGAAAGTGAACA | + | 6.35 | | PRDM1 | MA0508.2 | chr1:173376032-173376042 | GTGAAAGTGA | - | 6.02 | | PRDM1 | MA0508.2 | chr1:173376038-173376048 | GTGAAAGTGA | - | 6.02 | | ZNF263 | MA0528.1 | chr1:173376083-173376104 | TGAGCAGGGCGAGGAGGGGAA | + | 6.44 |
|
| | Number of super-enhancer constituents: 3 | ID | Coordinate | Tissue/cell |
| SE_11670 | chr1:173375124-173388930 | CD20 | | SE_59309 | chr1:173375281-173399883 | Ly3 | | SE_61594 | chr1:173375372-173401064 | Toledo |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I173406 | chr1 | 173375740 | 173377277 |
|
Enhancer Sequence | TACTTATTTC ACAAAAATTA TTAAATACCT ACTATGTTCC AGGAACTCTA CAGGGAATTT 60
GGCCTACATA GCTAACGAAG ACATTACAGG GTTGCATTAT AACTTCCATG AGTCCTAGGC 120
ACTTTTGCCT TCATGGACCC CTTCTTCCAT TAAAAAAATT AAAATTTTTA TTTTACATTG 180
TCTTAAAGAT AAATATAATT CAGGCCGGAT TCATTGCTAT GTTCTTAATT ATTATACTCA 240
CTATTTCTTC AGAATTTAAA AGCAATTAAT ATGAAAACAT TGTCGTGGAC CCTAAAATTA 300
CCCTGGGCCC TGGGCTCTGT GTCTGTTGTG CCCAGTGGGG CGATTGCCCT GCGACAGTCT 360
CTGTCTTCCT GCCTCCTGTC CTGAATGAAT CGGTCCAAAT GTTACTCAAA GGAGCTGATC 420
AAAGTAGCTG GGACCTGGAG AGAATTCCCA GGTGTGGGAA TCCTGAGAGG TAATTACGGA 480
GAGCTTCCGA ATGGAGAGCC TGTGGCCGTG GGGTGAAAGT GAAAGTGAAC AGTGACAGCG 540
GCCTGTTGGG TGGTACTGGG TTCTGAGCAG GGCGAGGAGG GGAATCTAGT TGGGGGGATG 600
GGGAGACAGT AGCAATGGCA AGGCAGGATA TTACAGCAGC AGCAGGATGA GAAGGGTGAC 660
TGCCTCACTC GGTGCAGACT GCTGGCACCT GAGTGGAGTA AGGCTGATGG CTGTGCAGGG 720
AGCAAAGGCA GTGGCCACTG GGGAGGCAGG TGGTGCGGGA GGGGAGAAAA GCAGACCAAA 780
CAGCCTGGCT GGGGTGTTGG GGCCCAAGAA GGATGAGGAG GATATTAGCA CAGTCCGTGT 840
GGAGTGTCAG AACCTGAGGG TAGATCAAGG TAACCAGCTT CTCACAGTCA GAAAAAGAAG 900
TTACAAATCT GGCCAGGCGC GGTGGCTCAC ACCTATAATC CCAGCACTTT GGGAGGCCAA 960
GGTGGGCAAA TCACTTGAGA CCACCCTAGG CGATATGACG AAACCCCGTC TCCATAAAAA 1020
GTATAAAAAT TTGTCGGGTG TGGTCGCACA CACCTGTAAT CCCAGCTACT CAGGAGGCTG 1080
AGGTAGAATA ATCACTTGAG CCCAGGAAGT GGAGGTTGCA ATGAGCTGAG ATCATGCCAC 1140
TGCACTCCAG CCTGGGTGAC AGAGCAAGAC TCTGCCTCAA AAAAAAAAAA AAAAAAAAAA 1200
AAGTTACAAA TCTGGAAAGT GAAAACTAGA ATGAATCTGT GCTGCTGTAG ATTAAAATCA 1260
TCACTATCAG CATGAATTCA TGCTTTCCTG TAATATACAG ATATAAAACT AGATGTAAAT 1320
GGGTGTGTGT GTGTGTGTGT GTGTGTGTCC TAGCTCTATA CATTGAGAGC CTGGGAGCAG 1380
AGACATCCCA ATAGCAATGA ACACAGCTAT CATCCATATT TTGATTTCTG CTATGGTTTG 1440
ACAGTTTTTA TCCCCTACAA AATTCATATA TTTAAATCCT AATCCCCAGA GTGATGGTAT 1500
TAGGAGGTGG GGACTTTGGG AGGTGATAAG GTCATCAGGG CAGAGGTCCA GGTATGGGAC 1560
TCATGCCCTT ATAGAAGAGG CTCAGAGAAC TGCCTTGCCC CTTACACAGC CAGAAAGTTG 1620
GCAATCTGCA TCTCACAGGC AAACCCTCAT CAGACCCCAA CCATGCTGGC ACCCTCATCT 1680
TGAACTTACC AGCCTCCAGA TCTGTGGAAA ATACACTTCT GTTGTTTATA AGCTAACCAG 1740
TCTATGATAT TTGTTATAGC AACCCAAACA GACTAAGACA ACTTCTAAAT ACCATTTTCC 1800
ATGAAAAAGA GCCAGGCCCC TCAGGAGAAA TGGCAGGAAA ATTACAAGAT GAGTTTGGAA 1860
TATCTTGTTG TTCCAGAAGG CAAGGACATG TACAAAGAAT GATAGGAACA GGCAAGAAAA 1920
TATACAAAGA ATGATAGGAA CACTGGCCAA ATTGGGAACA ATTTGATGAA AACAGATTAG 1980
AACCCAATAG ATAAAATAAG CTTCCATGGG TCCATACTAA TATAAATAAT 2030
|
